Exploring the glycolytic cross-talk genes between inflammatory bowel disease and colorectal cancer.

"Declarations Ethics approval and consent to participateThe studies involving human participants were reviewed and approved by Ethics Committee of Renmin Hospital of Wuhan University (WDRY2021-KS066). All methods were performed in accordance with the relevant guidelines and the Declaration of Helsinki. The age of all participants is greater than 16 years old, and written informed consent to participate in this study was provided by the participants. Conflict of interestThe authors declare no competing interests. Conflict of interest The authors declare no competing interests."

"Funding This work was supported by the National Natural Science Foundation of China (No. 82202524 and 62276191) and Open Foundation of Hubei Key Laboratory (2021KFY004 and 2021KFY002)."